![](https://investorshub.advfn.com/uicon/789488.png?cb=1625048222)
Friday, August 27, 2021 9:05:35 AM
8:00 am ET August 27, 2021 (PR Newswire) Print
HealthLynked, Corp. (OTCQB: HLYK) ("HealthLynked" or the "Company"), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients, and medical data, today announced that it has entered into a securities purchase agreement with an institutional investor for the purchase and sale, in a registered direct offering, of 3,703,704 shares of its common stock at a purchase price of $0.54 per share for gross proceeds of $2,000,000. The Company has also agreed to issue to the investor unregistered warrants to purchase up to an aggregate of 1,851,852 shares of common stock. The offering is expected to close on or about August 31, 2021, subject to satisfaction of customary closing conditions.
The Company intends to use the net proceeds from the registered direct offering for general working capital purposes.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The warrants have an exercise price equal to $0.65 per share, are exercisable immediately upon issuance and will expire five years from the issuance date.
The shares of common stock described above (but not the warrants or the common shares underlying the warrants) are being offered and sold by the Company in a registered direct offering pursuant to a "shelf" registration statement on Form S-3 (File No. 333-255371), including a base prospectus previously filed with the Securities and Exchange Commission (the "SEC"), which was declared effective on April 26, 2021. The offering of the shares of common stock is being made only by means of a prospectus supplement that forms a part of the effective registration statement. A final prospectus supplement and the accompanying base prospectus relating to the shares of common stock being offered in the registered direct offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying base prospectus may also be obtained, when available, from H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 856-5711 or e-mail at placements@hcwco.com
The warrants described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act"), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Act, or applicable state securities laws. Accordingly, the warrants and the underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About HealthLynked
HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries, and personal health records, in one convenient online and secure location, free of charge. Participating healthcare providers can connect with their current and future patients through the system. Benefits to in-network providers include the ability to utilize the HealthLynked patent-pending patient access hub "PAH" for patient analytics. Other benefits for preferred providers include HLYK marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling, and to fill last-minute cancelations using the Company's "real-time appointment scheduling" all within its mobile application. Preferred providers pay a monthly fee to access these HealthLynked services. For additional information about HealthLynked Corp., please visit www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, and LinkedIn.
Forward-Looking Statements
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, among others, statements regarding the consummation of the registered direct offering, the satisfaction of customary closing conditions related to the registered direct offering and the intended use of net proceeds from the registered direct offering. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at www.sec.gov.
Contacts:
George O'LearyChief Financial Officergoleary@healthlynked.com (800)-928-7144, ext. 103
William HaydeCapital Markets Strategistbhayde@healthlynked.com (631)-403-4337
Investor Relations Contacts:Jim HockHanover International Inc.jh@hanoverintlinc.com (760)-564-7400
https://c212.net/c/img/favicon.png?sn=LN88314&sd=2021-08-27
View original content:https://www.prnewswire.com/news-releases/healthlynked-announces-2-million-registered-direct-offering-301364058.html
SOURCE HealthLynked Corp.
https://rt.prnewswire.com/rt.gif?NewsItemId=LN88314&Transmission_Id=202108270800PR_NEWS_USPR_____LN88314&DateId=20210827
comtex tracking
COMTEX_392297525/1005/2021-08-27T08:00:20
Recent HLYK News
- HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • InvestorsHub NewsWire • 06/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:00:28 PM
- Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • InvestorsHub NewsWire • 06/05/2024 12:00:00 PM
- HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • InvestorsHub NewsWire • 05/28/2024 12:00:00 PM
- HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • InvestorsHub NewsWire • 05/16/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:01:34 PM
- HealthLynked Announces Fourth Quarter and Full Year 2023 Results Highlighted by 70% Reduction in Net Loss for Q4 • InvestorsHub NewsWire • 04/02/2024 12:00:00 PM
- HealthLynked Announces Exciting New Update with HealthLynked 3.2.0 - Transforming Patient-Care Through Innovation • InvestorsHub NewsWire • 03/26/2024 12:00:00 PM
- HealthLynked Corp Announces Chris Hall as New Chief Technology Officer • InvestorsHub NewsWire • 03/19/2024 12:00:00 PM
- HealthLynked Welcomes David Rosal as New Chief Financial Officer • InvestorsHub NewsWire • 03/13/2024 12:00:00 PM
- HealthLynked Welcomes Garrett Gardi to Its Advisory Board • InvestorsHub NewsWire • 02/28/2024 01:00:00 PM
- HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary "Forever: The End of Aging," Now Available for Streaming • InvestorsHub NewsWire • 01/24/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 08:57:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:05:14 PM
- HealthLynked Unveils Advanced Search Functionality to Improve Patient Care • InvestorsHub NewsWire • 12/13/2023 01:00:00 PM
- HealthLynked Announces Q3 & Year-to-Date 2023 Financial Results, Highlighted by 8% Revenue Growth and Net Income Turnaround • InvestorsHub NewsWire • 11/15/2023 01:00:00 PM
- Introducing the New HealthLynked COVID-19 Tracker: A Comprehensive Tool for the Modern Pandemic Era • InvestorsHub NewsWire • 10/12/2023 12:00:00 PM
- HealthLynked Receives Medicare Shared Savings Net Proceeds from Sale of ACO Health Partners • InvestorsHub NewsWire • 10/09/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:28 PM
- HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • InvestorsHub NewsWire • 10/03/2023 12:00:00 PM
- HealthLynked Achieves Key Milestone with Final $300,000 Payment from Sale of ACO Health Partners • InvestorsHub NewsWire • 09/05/2023 12:00:00 PM
- HealthLynked Announces Steady YoY Revenue Increase for Q2 & H1 2023, Highlighting Significant Net Income Boost • InvestorsHub NewsWire • 08/15/2023 12:21:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:12:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM